ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.480,89
0,21%
S&P 500
5.187,67
0,00%
US Dollar vs BRL
5,0885
0,27%
Bitcoin
61.644,64
-1,11%
Brent Oil
83,565
0,84%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) Notícias

AZN

Astrazeneca (AZN)

Astrazeneca Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:AZN
DataHoraFonteTítuloCódigoCompanhia
08/05/202405:44Alliance NewsAlliance NewsAstraZeneca says withdraws Covid vaccine "for commercial reasons"LSE:AZNAstrazeneca Plc
07/05/202403:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca completes Cellectis equity investmentLSE:AZNAstrazeneca Plc
06/05/202403:46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
02/05/202406:04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202403:00RNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
01/05/202411:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
29/04/202405:13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202403:05RNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
29/04/202403:00RNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
25/04/202409:00PR Newswire (US)AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLSE:AZNAstrazeneca Plc
25/04/202405:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
25/04/202403:00RNS Regulatory NewsAstraZeneca PLC 1st Quarter ResultsLSE:AZNAstrazeneca Plc
24/04/202406:32Alliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AZNAstrazeneca Plc
16/04/202407:38Alliance NewsAlliance NewsIN THE KNOW: Deutsche ups AstraZeneca as higher payout addresses worryLSE:AZNAstrazeneca Plc
16/04/202404:39Alliance NewsAlliance NewsAstraZeneca's hails Imfinzi survival data on cancer formLSE:AZNAstrazeneca Plc
11/04/202413:42Alliance NewsAlliance News*AstraZeneca AGM resolutions pass, but 36% vote against remuneration policyLSE:AZNAstrazeneca Plc
11/04/202413:30RNS Regulatory NewsAstraZeneca PLC Result of AGMLSE:AZNAstrazeneca Plc
11/04/202404:56Alliance NewsAlliance NewsTOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023LSE:AZNAstrazeneca Plc
11/04/202403:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca increases 2024 dividend by 7%LSE:AZNAstrazeneca Plc
08/04/202404:36Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails neurological data for Ultomiris, SolirisLSE:AZNAstrazeneca Plc
08/04/202403:00RNS Regulatory NewsAstraZeneca PLC Enhertu approved in US for HER2+ solid tumoursLSE:AZNAstrazeneca Plc
08/04/202402:53Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approvalLSE:AZNAstrazeneca Plc
05/04/202405:42Alliance NewsAlliance NewsAstraZeneca makes "breakthrough" in treating small cell lung cancerLSE:AZNAstrazeneca Plc
05/04/202403:00RNS Regulatory NewsAstraZeneca PLC Imfinzi improved OS & PFS in limited-stage SCLCLSE:AZNAstrazeneca Plc
03/04/202407:02Alliance NewsAlliance NewsCORRECT: AstraZeneca, Daiichi make US progress with licence approvalsLSE:AZNAstrazeneca Plc
02/04/202406:25Alliance NewsAlliance NewsAstraZeneca and Daiichi make US progress with latest licence approvalsLSE:AZNAstrazeneca Plc
02/04/202403:05RNS Regulatory NewsAstraZeneca PLC Voydeya approved in USLSE:AZNAstrazeneca Plc
02/04/202403:00RNS Regulatory NewsAstraZeneca PLC FDA accepts Dato-DXd BLA for breast cancerLSE:AZNAstrazeneca Plc
27/03/202406:19Alliance NewsAlliance NewsAstraZeneca treatments become "first and only" to be approved in JapanLSE:AZNAstrazeneca Plc
25/03/202405:40Alliance NewsAlliance NewsTOP NEWS: AstraZeneca wins US approval for rare nervous system diseaseLSE:AZNAstrazeneca Plc
 Apresentando as notícias mais relevantes sobre:LSE:AZN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PRIO3
PETRORIO ON
BOV
VVEO3
CM Hospitalar ON
BOV
ETER3
ETERNIT ON
BOV
COGN3
COGNA ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
CRFB3
CARREFOUR ON
BOV
SGPS3
SPRINGS ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
OIBR3
OI ON
BOV
TELB4
TELEBRAS PN
BOV
BRKM5
BRASKEM PNA
BOV
RNEW4
RENOVA PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados